|Last Updated: October 23, 2021 @ 9:13 am|
Hepatitis B Screen, Pre-Vaccination
|Stability:||Ambient: 2 Hour(s); Refrigerated: 5 Day(s); Frozen: 3 Month(s); Incubated: Unacceptable|
|Interpretive Data:||Please see report for interpretive data.|
HBsAg AND ANTI-HBs INTERPRETIVE NOTES:
NEGATIVE HBsAg AND NEGATIVE ANTI-HBs: NO SEROLOGIC EVIDENCE OF HEPATITIS B VIRUS INFECTION OR IMMUNITY TO FUTURE HEPATITIS B VIRUS INFECTIONS. PATIENT IS A CANDIDATE FOR THE HEPATITIS B VACCINE.
NEGATIVE HBsAg AND POSITIVE ANTI-HBs: THE PATIENT IS CURRENTLY IMMUNE TO FUTURE INFECTION WITH HEPATITIS B VIRUS.
POSITIVE HBsAg AND NEGATIVE ANTI-HBs: CONSISTENT WITH ACTIVE (EARLY ACUTE OR LATE CHRONIC) HEPATITIS B VIRUS INFECTION. PATIENT IS INFECTIVE FOR HEPATITIS B.
POSITIVE HBsAg AND POSITIVE ANTI-HBs: THIS PATTERN MAY INDICATE CHRONIC HEPATITIS B VIRUS INFECTION. ORDER HEPATITIS B PANEL.
Biotin in specimens taken from patients on high-dose biotin therapy or supplements may intefere with at least one test in this panel and cause inaccurate test results. It is recommended that for patients receiving therapy with high biotin doses (> 5 mg/day), no laboratory test specimen should be taken until at least 8 hours after the last biotin administration.
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date.
Updated test information can only be guaranteed by using this website.